These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9110062)

  • 1. Clinical implications of alpha 1 adrenergic blockade and angiotensin converting enzyme inhibition 'cross talk' in heart failure in Nigerians.
    Ajayi AA; Sofowora G; Balogun MO
    Afr J Med Med Sci; 1996 Mar; 25(1):95. PubMed ID: 9110062
    [No Abstract]   [Full Text] [Related]  

  • 2. Concurrent alpha 1 adrenergic blockade and angiotensin converting enzyme inhibition in the treatment of congestive heart failure.
    Ajayi AA; Sofowora GG; Balogun MO
    Int J Cardiol; 1996 Dec; 57(2):173-6. PubMed ID: 9013270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
    Ethn Dis; 2003; 13(1):71-9. PubMed ID: 12723015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between alpha 1-blockade and angiotensin converting enzyme inhibition in essential hypertension.
    Brown MJ; Dickerson JE
    J Hypertens Suppl; 1991 Dec; 9(6):S362-3. PubMed ID: 1687874
    [No Abstract]   [Full Text] [Related]  

  • 5. For the patient. New treatments for heart failure in Black people. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
    Ethn Dis; 2003; 13(1):150. PubMed ID: 12723027
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.
    Patki KC; Joglekar SJ; Kamat SK; Thatte UM; Yeolekar ME; Rege NN; Dahanukar SA; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():26-9. PubMed ID: 11229106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA; Berezin AE
    Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
    Guazzi M; Agostoni P
    Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral therapy with combined enalapril, prazosin and hydrochlorothiazide in the acute treatment of severe hypertension in Nigerians.
    Ajayi AA; Afolabi MA; Balogun MO; Adigun AQ; Ajayi OE; Akintomide AO
    Eur J Clin Pharmacol; 1996; 51(1):45-8. PubMed ID: 8880050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of enap and oliphen combined treatment of chronic pulmonary hypertension].
    Shkol'nik MA; Butorov IV; Fuduleĭ RF; Paraska VI; Bodrug NI
    Klin Med (Mosk); 1999; 77(6):26-7. PubMed ID: 10459215
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
    Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
    Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ednit in the treatment of congestive heart failure in chronic obstructive bronchitis].
    Shkol'nik MA; Sheĭkh AT; Butorov IV; Duduleĭ RF
    Klin Med (Mosk); 2000; 78(7):56-8. PubMed ID: 10979645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Risk reduction of acute heart failure with initial administration of beta-blockers].
    Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD; Goedde M; Berger K; Kiowski W
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.